These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 11466867)

  • 1. [A vaccination would prevent invasive pneumococcal infections in adults].
    Herva E; Sankilampi U; Leinonen M
    Duodecim; 1997; 113(8):689-91. PubMed ID: 11466867
    [No Abstract]   [Full Text] [Related]  

  • 2. Missed opportunities in vaccination of patients with subsequent pneumococcal bacteraemia.
    Weightman NC; Walters A
    Br J Gen Pract; 2003 Jul; 53(492):547-9. PubMed ID: 14694668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preventing pneumococcal disease.
    Dobkin JF
    AIDS Read; 2006 Feb; 16(2):81-2. PubMed ID: 16471273
    [No Abstract]   [Full Text] [Related]  

  • 4. Invasive pneumococcal infection in first nations children in northern Alberta.
    Vaudry W; Talling D
    Can Commun Dis Rep; 2002 Oct; 28(20):165-72. PubMed ID: 12402519
    [No Abstract]   [Full Text] [Related]  

  • 5. Pneumococcal vaccination in older adults.
    Hirschmann JV
    N Engl J Med; 2003 Aug; 349(7):712-4; author reply 712-4. PubMed ID: 12917315
    [No Abstract]   [Full Text] [Related]  

  • 6. Inferring the potential success of pneumococcal vaccination in Italy: serotypes and antibiotic resistance of Streptococcus pneumoniae isolates from invasive diseases.
    Pantosti A; Boccia D; D'Ambrosio F; Recchia S; Orefici G; Moro ML; ;
    Microb Drug Resist; 2003; 9 Suppl 1():S61-8. PubMed ID: 14633369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pneumococcal vaccination in older adults.
    Fedson DS
    N Engl J Med; 2003 Aug; 349(7):712-4; author reply 712-4. PubMed ID: 12924341
    [No Abstract]   [Full Text] [Related]  

  • 8. Cost-effectiveness analysis of a universal vaccination programme with the 7-valent pneumococcal conjugate vaccine (PCV-7) in Sweden.
    Bergman A; Hjelmgren J; Ortqvist A; Wisløff T; Kristiansen IS; Högberg LD; Persson KM; Persson U
    Scand J Infect Dis; 2008; 40(9):721-9. PubMed ID: 18712627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pneumococcal vaccination in older adults.
    Marras TK
    N Engl J Med; 2003 Aug; 349(7):712-4; author reply 712-4. PubMed ID: 12924340
    [No Abstract]   [Full Text] [Related]  

  • 10. Pneumococcal bacteraemia and opportunities for prevention.
    Drinkovic D; Wong CG; Taylor SL; Roberts SA; Morris AJ
    N Z Med J; 2001 Jul; 114(1136):326-8. PubMed ID: 11548097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Influenza and pneumococcal vaccination in adults].
    Weinke T; Güthoff W
    Dtsch Med Wochenschr; 2009 Apr; 134 Suppl 2():S82-5. PubMed ID: 19353477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pneumococcal infections. Every second fatality within 48 hours].
    MMW Fortschr Med; 2001 Nov; 143(47):60. PubMed ID: 11791369
    [No Abstract]   [Full Text] [Related]  

  • 13. HHS-CDC news: Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease--US, 1998-2003.
    Ann Pharmacother; 2005 Nov; 39(11):1967-8. PubMed ID: 16219891
    [No Abstract]   [Full Text] [Related]  

  • 14. Pneumococcal vaccination for Indian children.
    Levine OS; Cherian T
    Indian Pediatr; 2007 Jul; 44(7):491-6. PubMed ID: 17684301
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pharmaco-economic aspects of vaccination against invasive pneumococcal infections in persons over 65 years of age; review of the literature on cost effectiveness analysis].
    Postma MJ; Heijnen ML; Beutels P; Jager JC
    Ned Tijdschr Geneeskd; 2002 May; 146(18):855-9. PubMed ID: 12038224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pediatric hospitalization for pneumococcal diseases preventable by 7-valent pneumococcal conjugate vaccine in Hong Kong.
    Ho PL; Chiu SS; Chow FK; Mak GC; Lau YL
    Vaccine; 2007 Sep; 25(39-40):6837-41. PubMed ID: 17714837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pneumococcal vaccination for persons 65 years of age and older].
    van den Bosch WJ
    Ned Tijdschr Geneeskd; 2002 May; 146(18):838-9. PubMed ID: 12038219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adults with invasive pneumococcal disease: missed opportunities for vaccination.
    Kyaw MH; Greene CM; Schaffner W; Ray SM; Shapiro M; Barrett NL; Gershman K; Craig AS; Roberson A; Zell ER; Schuchat A; Bennett NM; Whitney CG;
    Am J Prev Med; 2006 Oct; 31(4):286-92. PubMed ID: 16979452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influenza and pneumococcal vaccination coverage among persons aged > or =65 years and persons aged 18-64 years with diabetes or asthma--United States, 2003.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2004 Nov; 53(43):1007-12. PubMed ID: 15525897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacoeconomics of elderly vaccination against invasive pneumococcal infections: cost-effectiveness analyses and implications for The Netherlands.
    Postma MJ; Heijnen ML; Beutels P; Jager JC
    Expert Rev Vaccines; 2003 Aug; 2(4):477-82. PubMed ID: 14711333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.